Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

Decatur, Ga.-based Emory Heart and Vascular Center completed its 500th left ventricular assist device implantation. This year alone, Emory surgeons have implanted approximately 60 LVADs and expect to ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure ...

Two years ago, on a family skiing trip to Colorado, Toby Wise was struggling to keep up. Wise, 45, had always been in good health, played football in high school and played in a softball league and a ...

St. Jude Medical, Inc, a global medical device company, on Tuesday announced approval and launch of the HeartMate 3™ Left Ventricular Assist System (LVAS) in India. "The HeartMate 3 system allows me ...

Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...

Physicians at Washington, D.C.-based MedStar Washington Hospital Center have completed the 300th implant of the HeartMate 3 left ventricular assist device, which treats patients with advanced heart ...

Interstitial Decongestion in Acute Decompensated Heart Failure Patients With the eLym System: Percutaneous Device to Support Lymphatic Drainage: The Early Results of the DELTA-HF Feasibility Study ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...